ICT-121 / EOM Pharma 
Welcome,         Profile    Billing    Logout  
 10 Diseases   0 Trials   0 Trials   8 News 
  • ||||||||||  ICT-121 / EOM Pharma
    Trial completion, Trial completion date, Trial primary completion date:  A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (clinicaltrials.gov) -  Aug 13, 2018   
    P1,  N=20, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Mar 2017 | Trial primary completion date: Nov 2017 --> Mar 2017
  • ||||||||||  ICT-121 / EOM Pharma
    Enrollment closed:  A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (clinicaltrials.gov) -  Sep 22, 2016   
    P1,  N=20, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Mar 2017 | Trial primary completion date: Nov 2017 --> Mar 2017 Recruiting --> Active, not recruiting
  • ||||||||||  ICT-121 / EOM Pharma
    Trial primary completion date:  A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (clinicaltrials.gov) -  Feb 4, 2016   
    P1,  N=20, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2015 --> Nov 2017
  • ||||||||||  ICT-121 / EOM Pharma
    Trial primary completion date:  A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (clinicaltrials.gov) -  May 15, 2014   
    P1,  N=20, Recruiting, 
    Trial primary completion date: Dec 2015 --> Nov 2017 Trial primary completion date: Jan 2015 --> Dec 2015